FEBRUARY 18, 2012

Browse Categories

ASCO 2008 Annual Meeting - Sequential Axitinib (AG-013736) Therapy of Patients (pts) with Metastatic Clear Cell Renal Cell Cancer (RCC) Refractory to Sunitinib and Sorafenib, Cytokines and Sorafenib, or Sorafenib Alone

Wed, 13 August 2008
E-mail Print

Abstract No.: 5127
Citation: J Clin Oncol 26: 2008 (May 20 suppl; abstr 5127))
Author(s): J. P. Dutcher, G. Wilding, G. R. Hudes, W. M. Stadler, S. Kim, J. C. Tarazi, B. Rosbrook, B. I. Rini




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |